LON:SBTX SkinBioTherapeutics (SBTX) Share Forecast, Price & News GBX 20.90 -0.35 (-1.65%) (As of 11:30 AM ET) Add Compare Share Share Today's Range 20.51▼ 21.3550-Day Range 11.90▼ 24.2552-Week Range 11▼ 27Volume171,104 shsAverage Volume427,636 shsMarket Capitalization£36.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesProfileChartCompetitorsInsider TradesHeadlines About SkinBioTherapeutics (LON:SBTX) StockSkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health. It develops SkinBiotix technology that can enhance the formation of multi-protein complexes and prevent passage toxins, molecules, and ions, as well as pathogens; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has a collaboration agreement with Croda Plc; and the University of Manchester to develop bacterial lysates in the prevention of periodontal gun disease. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.Read More SBTX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBTX Stock News HeadlinesSeptember 23, 2023 | americanbankingnews.comSkinBioTherapeutics (LON:SBTX) Shares Down 1.2% September 14, 2023 | uk.investing.comFiverr International Ltd DRC (F2VR34)September 27, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. September 2, 2023 | uk.investing.comSocietatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA (ROH2O)July 11, 2023 | finance.yahoo.comSBTX.L - SkinBioTherapeutics PlcJune 21, 2023 | marketwatch.comSkinBioTherapeutics Gets Approval for Supplement Launch in ItalyMarch 30, 2023 | finance.yahoo.comSkinBioTherapeutics Reports First Half 2023 EarningsMarch 28, 2023 | marketwatch.comSkinBioTherapeutics Shares Fall on Widened 1H Pretax Loss From Higher CostsSeptember 27, 2023 | Wall Street Fundamentals (Ad)The "Plug and Play" Model Putting Online Giants to ShameWhile e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."March 22, 2023 | finance.yahoo.comIs SkinBioTherapeutics (LON:SBTX) In A Good Position To Invest In Growth?December 21, 2022 | marketwatch.comSkinBioTherapeutics Raises GBP2.6 Mln in Placing, Retail OfferDecember 15, 2022 | marketwatch.comSkinBioTherapeutics to Raise a Minimum of GBP2.5 MlnOctober 14, 2022 | finance.yahoo.comAfter losing 68% in the past year, SkinBioTherapeutics Plc (LON:SBTX) institutional owners must be relieved by the recent gainAugust 31, 2022 | lse.co.ukSkinBioTherapeutics shares fall as probiotic AxisBiotix-PS sales dropAugust 31, 2022 | marketwatch.comSkinBioTherapeutics Shares Fall After Worse-Than-Expected Supplement SalesJune 15, 2022 | proactiveinvestors.comSkinBioTherapeutics puzzled by share price, says feedback positive for psoriasis treatmentJune 13, 2022 | marketwatch.comSkinBioTherapeutics Knows No Reason For Share Price FallMay 20, 2022 | news.yahoo.comWhat It's Like Inside a Burning Drift CarMay 20, 2022 | news.yahoo.comReport raises concerns over lay-offs, cash flow at Cottage clinic; records issues resolvedMay 18, 2022 | finance.yahoo.comWe're Keeping An Eye On SkinBioTherapeutics' (LON:SBTX) Cash Burn RateMarch 29, 2022 | lse.co.ukSkinBioTherapeutics proposes Manprit Singh Randhawa as new CFOMarch 29, 2022 | marketwatch.comSkinBioTherapeutics Shares Drop 30% After Widened 1H Pretax LossFebruary 17, 2022 | finance.yahoo.comWhat Kind Of Shareholders Hold The Majority In SkinBioTherapeutics Plc's (LON:SBTX) Shares?January 19, 2022 | marketwatch.comSkinBioTherapeutics CFO to Step DownJanuary 18, 2022 | proactiveinvestors.comSkinBioTherapeutics seeks full-time finance chief and NED to guide social media strategyDecember 24, 2021 | markets.businessinsider.comSkinBioTherapeutics : Result of AGMDecember 4, 2021 | markets.businessinsider.comSkinBioTherapeutics : Notice of ResultsSee More Headlines Receive SBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SBTX Company Calendar Last Earnings3/03/2020Today9/27/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:SBTX CUSIPN/A CIKN/A Webwww.skinbiotherapeutics.com Phone+44-161-4682760FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-3,000,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-111.74% Return on Assets-60.12% Debt Debt-to-Equity Ratio9.03 Current Ratio1.77 Quick Ratio10.01 Sales & Book Value Annual Sales£21,949.00 Price / Sales1,648.65 Cash FlowGBX 2.32 per share Price / Cash Flow9.00 Book ValueGBX 1 per share Price / Book20.90Miscellaneous Outstanding Shares173,140,000Free FloatN/AMarket Cap£36.19 million OptionableNot Optionable Beta2.17 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Stuart John Ashman (Age 56)CEO & Exec. Director Comp: $325.85kMr. Manprit Singh Randhawa (Age 39)CFO, Sec. & Director Comp: $177.98kDr. Catherine O'NeillChief Scientific Officer & Member of Scientific Advisory BoardLaura BeyHead of FormulationsMs. Melissa GreenwellGroup Financial ControllerKey CompetitorsPoolbeg PharmaLON:POLBC4X DiscoveryLON:C4XDTissue Regenix GroupLON:TRXBiodexa PharmaceuticalsLON:MTPHCollagen Solutions plc (COS.L)LON:COSView All CompetitorsInsidersManprit Singh RandhawaSold 89,472 sharesTotal: £2.06 M ($23.00/share)View All Insider Transactions SBTX Stock - Frequently Asked Questions How have SBTX shares performed in 2023? SkinBioTherapeutics' stock was trading at GBX 15.50 at the beginning of the year. Since then, SBTX shares have increased by 34.8% and is now trading at GBX 20.90. View the best growth stocks for 2023 here. How were SkinBioTherapeutics' earnings last quarter? SkinBioTherapeutics Plc (LON:SBTX) released its earnings results on Tuesday, March, 3rd. The company reported ($0.64) EPS for the quarter. What other stocks do shareholders of SkinBioTherapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other SkinBioTherapeutics investors own include Avacta Group (AVCT), Inspired (INSE), OptiBiotix Health (OPTI), Lb-shell (LBP), Anglo African Oil & Gas (AAOG), Big Sofa Technologies Group (BST), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES) and Shield Therapeutics (STX). What is SkinBioTherapeutics' stock symbol? SkinBioTherapeutics trades on the London Stock Exchange (LON) under the ticker symbol "SBTX." How do I buy shares of SkinBioTherapeutics? Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is SkinBioTherapeutics' stock price today? One share of SBTX stock can currently be purchased for approximately GBX 20.90. How much money does SkinBioTherapeutics make? SkinBioTherapeutics (LON:SBTX) has a market capitalization of £36.19 million and generates £21,949.00 in revenue each year. The company earns £-3,000,000.00 in net income (profit) each year or GBX (0.02) on an earnings per share basis. How can I contact SkinBioTherapeutics? SkinBioTherapeutics' mailing address is 15 1 Silk House, Park Green, MACCLESFIELD, SK11 7QJ, United Kingdom. The official website for the company is www.skinbiotherapeutics.com. The company can be reached via phone at +44-161-4682760. This page (LON:SBTX) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.